SCM

Superstring Capital Management Portfolio holdings

AUM $140M
1-Year Est. Return 323.19%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+323.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$140M
AUM Growth
-$46.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
59
New
Increased
Reduced
Closed

Top Buys

1
+$14.4M
2
+$6M
3
+$5.82M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.13M
5
GMAB icon
Genmab
GMAB
+$5.02M

Top Sells

1
+$18.8M
2
+$17.9M
3
+$8.08M
4
URGN icon
UroGen Pharma
URGN
+$6.64M
5
COGT icon
Cogent Biosciences
COGT
+$5.21M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
26
Aclaris Therapeutics
ACRS
$628M
$1.37M 0.98%
+366,490
CLYM
27
Climb Bio
CLYM
$609M
$1.36M 0.97%
+199,209
TSHA icon
28
Taysha Gene Therapies
TSHA
$1.6B
$1.15M 0.82%
258,269
-722,499
DRUG
29
Bright Minds Biosciences
DRUG
$736M
$971K 0.69%
13,311
-33,967
TNXP icon
30
Tonix Pharmaceuticals
TNXP
$181M
$874K 0.62%
+63,540
CGEM icon
31
Cullinan Oncology
CGEM
$934M
$845K 0.6%
+59,484
TARA icon
32
Protara Therapeutics
TARA
$238M
$633K 0.45%
121,457
-238,543
PTN
33
Palatin Technologies, Inc. Common Stock
PTN
$24.3M
$627K 0.45%
35,969
+1,998
BMEA icon
34
Biomea Fusion
BMEA
$94.7M
$383K 0.27%
250,000
IPSC icon
35
Century Therapeutics
IPSC
$382M
$270K 0.19%
119,308
-343,655
ASMB icon
36
Assembly Biosciences
ASMB
$481M
– –
-65,273
AVTX icon
37
Avalo Therapeutics
AVTX
$732M
– –
-153,313
BLTE
38
Belite Bio
BLTE
$5.39B
– –
-24,703
CAPR icon
39
Capricor Therapeutics
CAPR
$1.59B
– –
-96,334
CDTX
40
DELISTED
Cidara Therapeutics
CDTX
– –
-85,098
DNTH icon
41
Dianthus Therapeutics
DNTH
$4.61B
– –
-26,249
DVAX
42
DELISTED
Dynavax Technologies
DVAX
– –
-525,592
ENTX icon
43
Entera Bio
ENTX
$60.1M
– –
-17,142
FOLD
44
DELISTED
Amicus Therapeutics
FOLD
– –
-352,896
FULC icon
45
Fulcrum Therapeutics
FULC
$213M
– –
-72,060
IVA
46
Inventiva
IVA
$842M
– –
-100,000
OCUL icon
47
Ocular Therapeutix
OCUL
$1.81B
– –
-418,080
PALI icon
48
Palisade Bio
PALI
$339M
– –
-367,103
QNCX icon
49
Quince Therapeutics
QNCX
$20.1M
– –
-85,871
RARE icon
50
Ultragenyx Pharmaceutical
RARE
$2.18B
– –
-31,738
1
2
3